The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rothenberg, M. E.
Right arrow Articles by Owen, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rothenberg, M. E.
Right arrow Articles by Owen, W. F., Jr

The Journal of Immunology, Vol 143, Issue 7 2311-2316, Copyright © 1989 by American Association of Immunologists


ARTICLES

IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity

ME Rothenberg, J Petersen, RL Stevens, DS Silberstein, DT McKenzie, KF Austen and WF Owen Jr
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Human peripheral blood-derived eosinophils were assessed for their viability, density, and functional properties after 7 days of culture with purified mouse IL-5 and mouse 3T3 fibroblasts. Whereas none of the eosinophils remained viable after 7 days of culture in the absence of IL-5, 38 +/- 12% and 61 +/- 14% (n = 6, mean +/- SD) of the eosinophils survived in the presence of 1 pM IL-5 alone or 1 pM IL-5 in the presence of 3T3 fibroblasts, respectively (p less than 0.05). Direct contact between the fibroblasts and the eosinophils was not needed for this enhanced IL-5-dependent viability. After 7 days, 66 +/- 7% (n = 6) of the cocultured eosinophils were viable when the two cell types were separated by a 0.4-microns filter. As assessed by density-gradient centrifugation after 7 days of IL-5 exposure, all of the original normodense eosinophils became hypodense. The time course of this conversion was accelerated by the presence of 3T3 fibroblasts. Enhanced helminthic cytotoxicity was maintained by the 7-day cultured eosinophils only if they had been cocultured with fibroblasts. Eosinophils killed 10 +/- 11% (n = 5), 48 +/- 17%, and 31 +/- 15% of the larvae when they were cultured for 7 days in IL-5 alone, in IL-5 in direct contact with 3T3 fibroblasts, or in IL-5 with filter separation of the fibroblasts and the eosinophils, respectively. The ability of IL- 5 to induce progenitor cells to differentiate selectively into eosinophils, and of 3T3 fibroblasts to facilitate the IL-5-mediated conversion of normodense eosinophils to hypodense eosinophils with increased viability and antibody-dependent cytotoxicity suggests a role for both hematopoietic and tissue factors in determining the presence and pathobiologic function of activated hypodense eosinophils in patients with hypereosinophilic conditions.


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Geoffrey, S. Jia, A. E. Kwitek, J. Woodliff, S. Ghosh, A. Lernmark, X. Wang, and M. J. Hessner
Evidence of a Functional Role for Mast Cells in the Development of Type 1 Diabetes Mellitus in the BioBreeding Rat
J. Immunol., November 15, 2006; 177(10): 7275 - 7286.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Xue, S. L. Gyles, F. R. Wettey, L. Gazi, E. Townsend, M. G. Hunter, and R. Pettipher
Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells
J. Immunol., November 15, 2005; 175(10): 6531 - 6536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Kimzey, P. Liu, and J. M. Green
Requirement for CD28 in the Effector Phase of Allergic Airway Inflammation
J. Immunol., July 1, 2004; 173(1): 632 - 640.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. B. Kay and A. Menzies-Gow
Eosinophils and Interleukin-5: The Debate Continues
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1586 - 1587.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. T. Flood-Page, A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson
Eosinophil's Role Remains Uncertain as Anti-Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 199 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. M. Robertson, J. G. Zangrilli, A. Steplewski, A. Hastie, R. G. Lindemeyer, M. A. Planeta, M. K. Smith, N. Innocent, A. Musani, R. Pascual, et al.
Differential Expression of TRAIL and TRAIL Receptors in Allergic Asthmatics Following Segmental Antigen Challenge: Evidence for a Role of TRAIL in Eosinophil Survival
J. Immunol., November 15, 2002; 169(10): 5986 - 5996.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Thivierge, M. Doty, J. Johnson, J. Stankova, and M. Rola-Pleszczynski
IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils
J. Immunol., November 1, 2000; 165(9): 5221 - 5226.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. S. Gounni, B. Gregory, E. Nutku, F. Aris, K. Latifa, E. Minshall, J. North, J. Tavernier, R. Levit, N. Nicolaides, et al.
Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils
Blood, September 15, 2000; 96(6): 2163 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Blease, B. Mehrad, T. J. Standiford, N. W. Lukacs, J. Gosling, L. Boring, I. F. Charo, S. L. Kunkel, and C. M. Hogaboam
Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2-/- Mice
J. Immunol., September 1, 2000; 165(5): 2603 - 2611.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M. Varga, P. Wachholz, K. T. Nouri-Aria, A. Verhoef, C. J. Corrigan, S. J. Till, and S. R. Durham
T Cells from Human Allergen-Induced Late Asthmatic Responses Express IL-12 Receptor {beta}2 Subunit mRNA and Respond to IL-12 In Vitro
J. Immunol., September 1, 2000; 165(5): 2877 - 2885.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. J. Evans, M. A. Lindsay, B. L. J. Webb, H. Kankaanranta, M. A. Giembycz, B. J. O'Connor, and P. J. Barnes
Expression and activation of protein kinase C-zeta in eosinophils after allergen challenge
Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L233 - L239.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Adachi, S. Stafford, S. Sur, and R. Alam
A Novel Lyn-Binding Peptide Inhibitor Blocks Eosinophil Differentiation, Survival, and Airway Eosinophilic Inflammation1, 2
J. Immunol., July 15, 1999; 163(2): 939 - 946.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Cowburn, S. T. Holgate, and A. P. Sampson
IL-5 Increases Expression of 5-Lipoxygenase-Activating Protein and Translocates 5-Lipoxygenase to the Nucleus in Human Blood Eosinophils
J. Immunol., July 1, 1999; 163(1): 456 - 465.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. P. Hallsworth, C. P. C. Soh, C. H. C. Twort, T. H. Lee, and S. J. Hirst
Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival.
Am. J. Respir. Cell Mol. Biol., December 1, 1998; 19(6): 910 - 919.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. Larche, S. J. Till, B. M. Haselden, J. North, J. Barkans, C. J. Corrigan, A. B. Kay, and D. S. Robinson
Costimulation Through CD86 Is Involved in Airway Antigen-Presenting Cell and T Cell Responses to Allergen in Atopic Asthmatics
J. Immunol., December 1, 1998; 161(11): 6375 - 6382.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Adachi and R. Alam
The mechanism of IL-5 signal transduction
Am J Physiol Cell Physiol, September 1, 1998; 275(3): C623 - C633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. J. TILL, S. R. DURHAM, K. RAJAKULASINGAM, M. HUMBERT, D. HUSTON, R. DICKASON, A. B. KAY, and C. J. CORRIGAN
Allergen-induced Proliferation and Interleukin-5 Production by Bronchoalveolar Lavage and Blood T Cells after Segmental Allergen Challenge
Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 404 - 411.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-U. Simon, S. Yousefi, B. Dibbert, H. Hebestreit, M. Weber, D. R. Branch, K. Blaser, F. Levi-Schaffer, and G. P. Anderson
Role for Tyrosine Phosphorylation and Lyn Tyrosine Kinase in Fas Receptor-Mediated Apoptosis in Eosinophils
Blood, July 15, 1998; 92(2): 547 - 557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Grewe, W. Czech, A. Morita, T. Werfel, M. Klammer, A. Kapp, T. Ruzicka, E. Schopf, and J. Krutmann
Human Eosinophils Produce Biologically Active IL-12: Implications for Control of T Cell Responses
J. Immunol., July 1, 1998; 161(1): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Okada, J. B. Hagan, M. Kato, J. L. Bankers-Fulbright, L. W. Hunt, G. J. Gleich, and H. Kita
Lidocaine and its Analogues Inhibit IL-5-Mediated Survival and Activation of Human Eosinophils
J. Immunol., April 15, 1998; 160(8): 4010 - 4017.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Hebestreit, B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser, and H.-U. Simon
Disruption of Fas Receptor Signaling by Nitric Oxide in Eosinophils
J. Exp. Med., February 2, 1998; 187(3): 415 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Q. Yuan, K. F. Austen, D. S. Friend, M. Heidtman, and J. A. Boyce
Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)-mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1)
J. Exp. Med., July 21, 1997; 186(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ochi, N. H. De Jesus, F. H. Hsieh, K. F. Austen, and J. A. Boyce
IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production
PNAS, September 12, 2000; 97(19): 10509 - 10513.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.